Psoriasis Treatment in Cuba: Coriodermina® & Advanced Dermatology

Psoriasis is a chronic autoimmune skin condition that causes rapid skin cell turnover, resulting in thick, red, scaly patches (plaques) on the skin. It affects approximately 2–3% of the global population and can significantly impact quality of life. Psoriasis is associated with systemic inflammation and may be linked to other health conditions including psoriatic arthritis, cardiovascular disease, and metabolic syndrome.

Cuba has developed Coriodermina®, a biotechnological treatment for psoriasis that offers an alternative approach to managing this chronic condition. Cuba's dermatology centers combine this biotech therapy with phototherapy, topical treatments, and comprehensive dermatological care.

The Cuban approach emphasizes personalized treatment plans based on psoriasis type, severity, affected areas, and the patient's overall health, offering international patients access to therapies and expertise that complement their existing treatment regimen.

The most common form is plaque psoriasis (psoriasis vulgaris), which presents as raised, red patches covered with silvery-white scales. These plaques typically appear on the elbows, knees, scalp, and lower back, but can affect any skin area. Symptoms may include itching, burning, skin cracking, and nail changes (pitting, discoloration, separation).

Other types include guttate psoriasis (small, drop-shaped lesions), inverse psoriasis (smooth red patches in skin folds), pustular psoriasis (white pustules surrounded by red skin), and erythrodermic psoriasis (widespread redness and shedding). Psoriatic arthritis affects up to 30% of psoriasis patients, causing joint pain, stiffness, and swelling.

Psoriasis typically follows a pattern of flare-ups and remissions. Triggers may include stress, infections, certain medications, skin injuries (Koebner phenomenon), weather changes, and alcohol or tobacco use.

Psoriasis is usually diagnosed through clinical examination by a dermatologist. The characteristic appearance of plaques — well-defined red patches with silvery scales — is often sufficient for diagnosis. In uncertain cases, a skin biopsy may be performed to confirm the diagnosis.

Assessment includes determining psoriasis type, measuring severity (using scales such as PASI — Psoriasis Area and Severity Index), evaluating affected body surface area, and screening for associated conditions including psoriatic arthritis, cardiovascular risk factors, and metabolic syndrome.

Cuban dermatology specialists perform a comprehensive assessment to guide treatment planning and set realistic expectations for treatment outcomes.

Coriodermina® is a Cuban-developed biotechnological treatment for psoriasis. It is a topical medication that works by modulating the inflammatory processes and abnormal skin cell proliferation that underlie psoriasis. The treatment aims to reduce plaque formation, scaling, and inflammation.

Treatment protocols may combine Coriodermina® with phototherapy (UVB or PUVA), topical corticosteroids, and other dermatological treatments as appropriate. The dermatology team designs a personalized plan based on psoriasis type, severity, affected areas, and treatment history.

Treatment is delivered in specialized Cuban dermatology facilities with experienced specialists. Progress is monitored throughout the treatment period, and the protocol is adjusted based on response.

Coriodermina® therapy is suitable for most psoriasis patients, including those with plaque, guttate, and inverse psoriasis. The treatment may be appropriate for patients who have not achieved satisfactory results with conventional treatments or who are seeking complementary approaches.

Patients with severe erythrodermic or pustular psoriasis may require additional evaluation. A dermatology assessment is required to determine psoriasis type, severity, and the most appropriate treatment approach.

To begin the eligibility review, submit photographs of affected areas, dermatologist's report, PASI score if available, treatment history, and current medications through our consultation form.

Psoriasis treatment typically requires 2–4 weeks in Cuba. International patients receive comprehensive logistical support including medical visa assistance, airport reception, accommodation, translation services, and ground transportation.

A detailed cost estimate is provided after dermatology review. The program includes dermatology consultations, Coriodermina® medication, phototherapy sessions, monitoring, and all logistics. Costs vary based on psoriasis severity and treatment duration.

Our international patient services team coordinates all arrangements for patients and accompanying family members.